Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2018, 27(3):121-123

Comment on European Society of Cardiology to actualisation Guidelines for dual antiplatelet therapy

Moťovská Z
III. interní kardiologická klinika 3. LF UK a FN Královské Vinohrady, Praha, Česká republika

Published: March 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Moťovská Z. Comment on European Society of Cardiology to actualisation Guidelines for dual antiplatelet therapy. Cardiology Letters. 2018;27(3):121-123.
Download citation

References

  1. Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667-1678. Go to original source...
  2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
  3. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease. Eur Heart J. 2018; 39:213260. Go to original source...
  4. Schömig A, Neumann FJ, Kastrati A, et al. Randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084-1089. vysadiť obidva protidoštičkové lieky, treba zvážiť premosťujúcu liečbu cangrelorom (parenterálny inhibítor P2Y12), tirofibanom alebo eptifibatidom (inhibítory receptora trombocytov IIb/IIIa), a to najmä pokiaľ je operácia načasovaná skôr ako mesiac po PCI. U pacientov s vysokým ischemickým rizikom je vhodné operáciu odložiť o šesť mesiacov. Novinkou v odporúčaniach pre trojitú liečbu, DAPT spolu s perorálnym antikoagulačným liekom, je ohraničenie obdobia trojitej liečby na šesť mesiacov. U pacientov po implantácii koronárneho stentu by sa mala zvážiť jeden mesiac trvajúca trojitá liečba. U pacientov s vysokým ischemickým rizikom Go to original source...
  5. Yusuf S, Zhao F, Mehta SR, et al, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. Go to original source...
  6. Wallentin L, Becker RC, Budaj A, et al PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057. Go to original source...
  7. Wiviott SD, Braunwald E, McCabe CH, et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015. Go to original source...